Sapacitabine
From Self-sufficiency
File:Sapacitabine.png | |
Systematic (IUPAC) name | |
---|---|
1-(2-cyano-2-deoxy-β-D-arabinofuranosyl)-4-(palmitoylamino)pyrimidin-2(1H)-one | |
Identifiers | |
CAS Number | 151823-14-2 |
ATC code | none |
PubChem | CID 153970 |
Synonyms | N-[1-[(2R,3S,4S,5R)-3-Cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide |
Chemical data | |
Formula | C26H42N4O5 |
Molar mass | 490.64 g/mol[[Script error: No such module "String".]] |
Sapacitabine is a drug undergoing research for potential use in chemotherapy.[1][2]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
40px | This antineoplastic or immunomodulatory drug article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Chemotherapeutic agents
- Nitriles
- Nucleosides
- Pyrimidones
- Antineoplastic and immunomodulating drug stubs